Department of Infectious Disease, Imperial College London, London, UK; HIV Clinical Trials, Winston Churchill Wing, St Mary's Hospital, London, UK.
Department of Neurology, Yale University, New Haven, CT, USA.
Lancet HIV. 2020 Jul;7(7):e504-e513. doi: 10.1016/S2352-3018(20)30107-7.
High rates of cognitive disorders in antiretroviral-treated people living with HIV have been described worldwide. The exact prevalence of such cognitive disorders is determined by the definitions used, and the presence of these cognitive disorders significantly impacts the overall wellbeing of people with HIV. With the cohort of people with HIV becoming increasingly older, and having high rates of comorbidities and concomitant medication use, rates of cognitive disorders are likely to increase. Conversely, interventions are being sought to reduce the size of the latent HIV reservoir. If successful, such interventions are likely to also reduce the HIV reservoir in the brain compartment, which could result in improvements in cognitive function and reduced rates of impairment.
全球范围内都有报道称,接受抗逆转录病毒治疗的艾滋病毒感染者认知障碍的发生率很高。这种认知障碍的确切患病率取决于所使用的定义,而这些认知障碍的存在会显著影响艾滋病毒感染者的整体健康状况。随着艾滋病毒感染者群体年龄的增长,合并症和同时使用药物的比例也很高,认知障碍的发生率可能会增加。相反,人们正在寻求干预措施来减少潜伏性 HIV 储库的大小。如果这些干预措施成功,它们也可能会减少大脑中的 HIV 储库,从而改善认知功能,降低受损率。